<?xml version="1.0" encoding="UTF-8"?>
<ref id="B33" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Jabrane-Ferrat</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Nekrep</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Tosi</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Esserman</surname>
    <given-names class="given-names">L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Peterlin</surname>
    <given-names class="given-names">B. M.</given-names>
   </name>
  </person-group> (
  <year class="year">2003</year>). 
  <article-title class="article-title">MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?</article-title>
  <source class="source">Int. Immunol.</source>
  <volume class="volume">15</volume>, 
  <fpage class="fpage">467</fpage>â€“
  <lpage class="lpage">475</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1093/intimm/dxg048</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">12663676</pub-id>
 </mixed-citation>
</ref>
